RecruitingPhase 4NCT05381194

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Asan Medical Center
Intervention
BPaL(M) regimen(drug)
Enrollment
80 enrolled
Eligibility
19 years · All sexes
Timeline
2022 – 2027

Study locations (1)

Collaborators

Pusan National University Hospital · Samsung Medical Center · Seoul National University Hospital · Severance Hospital · Chonnam National University Hospital · The Catholic University of Korea · Chungbuk National University Hospital · Ulsan University Hospital · Soon Chun Hyang University · Incheon St.Mary's Hospital · DongGuk University · National Medical Center, Seoul

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05381194 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials